Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

182

Citations

29

References

2023

Year

Bradley J. Monk, Takafumi Toita, Xiaohua Wu, Juan Carlos Vázquez Limón, R. Tarnawski, Masaki Mandai, Ronnie Shapira‐Frommer, Umesh Mahantshetty, Maria Del Pilar Estevez-Diz, Qi Zhou,

The Lancet Oncology

Advanced Cervical CancerCervical Cancer ManagementCervical CancerCervical HealthMedicineMetronomic TherapyDurvalumab Versus PlaceboGynecologyCancer TreatmentPublic HealthOncologyRadiation OncologyGynecology Oncology

References

	Year	Citations

Page 1

Page 1